A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexFemale
Age18-55
SponsorPeking University Shenzhen Hospital

About this trial

The investigators are trying to determine if oral Probiotics(Umeta-mimi,30 days) with Metronidazole vaginal suppositories (7 days) is better than using Metronidazole vaginal suppositories(7 days) only in preventing the recurrence of bacterial vaginosis

Eligibility criteria

Qualifiers

Aged 18 to 55 years old, with history of sexual activity,

Amsel criterion for diagnosing BV

Sign informed consent

Disqualifiers

History of systemic organic diseases or psychiatric diseases

Planning for or during pregnancy, lactation, menstruation

within 5 days of onset of the disease, any antibiotics has been used

Long-term use of contraceptives or immunosuppressant

Trial design

Treatments tested in this trial

  • Metronidazole vaginal suppositories
  • Metronidazole vaginal suppositories and Probiotics(Umeta-mimi)

Treatment groups

140 Participants
are divided into 2 treatment groups

Sponsors and collaborators